631 related articles for article (PubMed ID: 12230479)
1. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
[TBL] [Abstract][Full Text] [Related]
2. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
5. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality.
de Waart DR; Zweers MM; Struijk DG; Krediet RT
Perit Dial Int; 2001; 21(3):269-74. PubMed ID: 11475342
[TBL] [Abstract][Full Text] [Related]
6. Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients.
García-López E; Anderstam B; Heimbürger O; Amici G; Werynski A; Lindholm B
Perit Dial Int; 2005; 25(2):181-91. PubMed ID: 15796147
[TBL] [Abstract][Full Text] [Related]
7. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
[TBL] [Abstract][Full Text] [Related]
8. A preceding exchange with polyglucose versus glucose solution modifies peritoneal equilibration test results.
Lilaj T; Dittrich E; Puttinger H; Schneider B; Haag-Weber M; Hörl WH; Vychytil A
Am J Kidney Dis; 2001 Jul; 38(1):118-26. PubMed ID: 11431191
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal transport characteristics with glucose polymer based dialysate.
Ho-dac-Pannekeet MM; Schouten N; Langendijk MJ; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1996 Sep; 50(3):979-86. PubMed ID: 8872974
[TBL] [Abstract][Full Text] [Related]
10. [Use of icodextrin for diurnal exchange in patients undergoing automatic peritoneal dialysis. Comparison with glucose solutions].
Bajo MA; Selgas R; del Peso G; Castro MJ; Hevia C; Gil F; Costero O; Olea T; Jiménez C
Nefrologia; 2002; 22(4):348-55. PubMed ID: 12369126
[TBL] [Abstract][Full Text] [Related]
11. Long Peritoneal Dialysis Dwells With Icodextrin: Kinetics of Transperitoneal Fluid and Polyglucose Transport.
Olszowska A; Waniewski J; Stachowska-Pietka J; Garcia-Lopez E; Lindholm B; Wańkowicz Z
Front Physiol; 2019; 10():1326. PubMed ID: 31736769
[No Abstract] [Full Text] [Related]
12. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
[TBL] [Abstract][Full Text] [Related]
13. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
[TBL] [Abstract][Full Text] [Related]
14. Predicting the Peritoneal Absorption of Icodextrin in Rats and Humans Including the Effect of α-Amylase Activity in Dialysate.
Akonur A; Holmes CJ; Leypoldt JK
Perit Dial Int; 2015; 35(3):288-96. PubMed ID: 24584610
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
Smit W; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
[TBL] [Abstract][Full Text] [Related]
16. Icodextrin: a review of its use in peritoneal dialysis.
Frampton JE; Plosker GL
Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
[TBL] [Abstract][Full Text] [Related]
18. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
[TBL] [Abstract][Full Text] [Related]
19. The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test.
Araújo Teixeira MR; Pecoits-Filho RF; Romão Junior JE; Sabbaga E; Marcondes MM; Abensur H
Perit Dial Int; 2002; 22(2):229-33. PubMed ID: 11990408
[TBL] [Abstract][Full Text] [Related]
20. Modelling of icodextrin hydrolysis and kinetics during peritoneal dialysis.
Stachowska-Pietka J; Waniewski J; Olszowska A; Garcia-Lopez E; Wankowicz Z; Lindholm B
Sci Rep; 2023 Apr; 13(1):6526. PubMed ID: 37085652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
